Skip to main content
Amicogen, Inc. logo

Amicogen, Inc. — Investor Relations & Filings

Ticker · 092040 ISIN · KR7092040005 LEI · 549300TN7B5XAO5U1H84 KO Manufacturing
Open in API
Filings indexed 410 across all filing types
Latest filing 2026-05-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 092040

About Amicogen, Inc.

http://amicogen.com/en/

Amicogen, Inc. is an industrial biotechnology company specializing in the development and production of specialty enzymes and proteins. The company operates across three primary business areas: Enzyme and Biopharmaceuticals, Healthcare and Nutrition, and Bioprocess and CDMO (Contract Development and Manufacturing Organization) services. Leveraging its proprietary enzyme technology, Amicogen creates innovative solutions for the biopharmaceutical, food, and cosmetics industries. The healthcare division develops and manufactures functional food ingredients and nutritional products. The company also provides bioprocess solutions, including protein purification resins and comprehensive CDMO services to support the biopharmaceutical sector.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is titled “분기보고서 (제 27기 1분기)” covering the period January 1 to March 31, 2026. It includes full interim financial statements (consolidated balance sheets, income statements, notes), business overview, management’s discussion and analysis, and auditor’s opinion—all hallmarks of a comprehensive quarterly report rather than a simple announcement or release. Therefore, it is classified as an Interim/Quarterly Report. Q1 2026
2026-05-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' which translates to 'Report on Ownership Status of Specific Securities by Executives and Major Shareholders.' It contains detailed information about the ownership changes of securities by an executive or major shareholder, including dates, share counts, and transaction details. The document is addressed to regulatory bodies such as the Securities and Futures Commission and the Korea Exchange, indicating it is a formal notification of insider share ownership changes. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length is 2631 characters, which is consistent with a detailed insider transaction report rather than a full financial report or announcement. Therefore, the correct classification is DIRS (Director's Dealing).
2026-05-04 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a detailed report on large shareholding status, including information about share ownership changes, major shareholders, and related legal disclosures. It references specific shareholding percentages, dates, and legal requirements under capital market laws. The content is consistent with a Major Shareholding Notification, which reports changes in significant share ownership levels crossing regulatory thresholds. There is no indication that this is an annual report, earnings release, or other financial report type. The document is not a brief announcement but a substantive filing about shareholding changes. Therefore, the appropriate classification is Major Shareholding Notification (MRQ).
2026-05-04 Korean
[기재정정]사업보고서 (2024.12)
Annual Report Classification · 100% confidence The document is titled '사업보고서' which translates to 'Business Report' or 'Annual Report' and references the 25th fiscal year (2024-01-01 to 2024-12-31). It contains detailed financial statements including balance sheets, income statements, cash flow statements, and notes to the financial statements. There are corrections to previously submitted financial data, indicating this is a corrected or amended annual report. The document also includes company overview, business description, management analysis, auditor's opinion, and governance information, typical of a comprehensive annual report. The length is substantial (15,000 characters), and it contains actual financial data and analysis, not just an announcement or certification. Therefore, it fits the definition of an Annual Report (10-K). FY 2024
2026-04-30 Korean
[기재정정]분기보고서 (2025.03)
Interim / Quarterly Report Classification · 100% confidence The document is titled '분기보고서' which translates to 'Quarterly Report' and references the 26th fiscal period 1st quarter (2025.01.01 to 2025.03.31). It contains detailed financial statements including balance sheets, statements of changes in equity, notes to financial statements, and extensive business and operational information. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement. The presence of detailed financial data and analysis confirms it is a comprehensive interim report for a period shorter than a full fiscal year. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q1 2025
2026-04-30 Korean
[기재정정]반기보고서 (2025.06)
Interim / Quarterly Report Classification · 95% confidence The document is titled '반기보고서' which translates to 'Interim Report' or 'Half-Year Report'. It references the 26th fiscal period half-year from January 1, 2025 to June 30, 2025. The content includes detailed financial statements such as balance sheets, capital changes, notes to financial statements, and other comprehensive financial and business information. The document is lengthy (15,000 characters) and contains actual financial data and analysis, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2025
2026-04-30 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.